UBS Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-85,575
| Closed | -$342K | – | 8831 |
|
|
2019
Q4 | $342K | Sell |
85,575
-994,792
| -92% | -$4.67M | ﹤0.01% | 5180 |
|
|
2019
Q3 | $5.29M | Buy |
1,080,367
+434,698
| +67% | +$2.43M | ﹤0.01% | 2340 |
|
|
2019
Q2 | $3.93M | Buy |
645,669
+641,118
| +14,087% | +$3.41M | ﹤0.01% | 2533 |
|
|
2019
Q1 | $26K | Buy |
4,551
+985
| +28% | +$10.2K | ﹤0.01% | 6085 |
|
|
2018
Q4 | $48K | Buy |
3,566
+1,642
| +85% | +$27.7K | ﹤0.01% | 6128 |
|
|
2018
Q3 | $37K | Sell |
1,924
-345
| -15% | -$7.34K | ﹤0.01% | 6406 |
|
|
2018
Q2 | $58K | Sell |
2,269
-6,222
| -73% | -$145K | ﹤0.01% | 5871 |
|
|
2018
Q1 | $171K | Buy |
8,491
+5,526
| +186% | +$129K | ﹤0.01% | 4881 |
|
|
2017
Q4 | $60K | Buy |
2,965
+1,927
| +186% | +$37.9K | ﹤0.01% | 5706 |
|
|
2017
Q3 | $22K | Sell |
1,038
-100
| -9% | -$1.69K | ﹤0.01% | 6390 |
|
|
2017
Q2 | $17K | Hold |
1,138
| – | – | ﹤0.01% | 6435 |
|
|
2017
Q1 | $18K | Sell |
1,138
-1,030
| -48% | -$14.9K | ﹤0.01% | 6236 |
|
|
2016
Q4 | $27K | Sell |
2,168
-5,502
| -72% | -$102K | ﹤0.01% | 6326 |
|
|
2016
Q3 | $215K | Sell |
7,670
-1,638
| -18% | -$55K | ﹤0.01% | 4498 |
|
|
2016
Q2 | $325K | Buy |
9,308
+326
| +4% | +$10.2K | ﹤0.01% | 4212 |
|
|
2016
Q1 | $246K | Sell |
8,982
-20,141
| -69% | -$593K | ﹤0.01% | 4348 |
|
|
2015
Q4 | $996K | Buy |
29,123
+1,688
| +6% | +$52.7K | ﹤0.01% | 3409 |
|
|
2015
Q3 | $788K | Sell |
27,435
-14,204
| -34% | -$607K | ﹤0.01% | 3562 |
|
|
2015
Q2 | $1.86M | Buy |
41,639
+6,950
| +20% | +$261K | ﹤0.01% | 3045 |
|
|
2015
Q1 | $1.2M | Buy |
34,689
+31,449
| +971% | +$856K | ﹤0.01% | 3415 |
|
|
2014
Q4 | $88K | Buy |
+3,240
| New | +$78.6K | ﹤0.01% | 5834 |
|
Other funds holding DPLO
UBS Group's DPLO Position: Q1 2020 in Review
UBS Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 85,575 shares — an estimated $342K sold.
UBS Group first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $5.29M in Q3 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- UBS Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- UBS Group sold 85,575 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $342K.
- UBS Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- UBS Group's DIPLOMAT PHARMACY, INC. position peaked at $5.29M in Q3 2019.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.